HTS HealthTech Summit 2014

Global Partners

Founded in 1805 in Geneva, Pictet & Cie is today one of Switzerland’s largest private banks, and the leading independent asset management specialist in Europe, with CHF 357 billion (EUR 297 billion) in assets under management and custody at June 2012. Pictet & Cie is a partnership owned and managed by eight general partners with unlimited liability for the bank’s commitments. The Pictet Group, based in Geneva, employs more than 3,200 staff. The group has offices in the following financial centres: Amsterdam, Barcelona, Basel, Dubai, Florence, Frankfurt, Hong Kong, Lausanne, London, Luxembourg, Madrid, Milan, Montreal, Nassau, Osaka, Paris, Rome, Singapore, Taipei, Turin, Tokyo and Zurich.
 

Gide is a premier international law firm. Founded in Paris in 1920, the firm now operates from 17 offices worldwide. With 600 lawyers, drawn from 35 different nationalities, Gide offers some of the most respected specialists in all sectors of national and international finance and business law.

In each of its offices in Europe, Asia, North America and Africa, Gide
provides its clients with comprehensive knowledge of local markets,
regional expertise, and the resources of an international law firm.
 

BondPR Worldwide is a global communications firm currently managing PR campaigns in over 50 countries for clients such as Autodesk, BroadVision, ClickSoftware, Dell SonicWall and Regus. BondPR offers streamlined, seamless and scalable campaigns through one point of contact, making world-class global PR available to technology and business to business clients without the hassle and overhead typically associated with international PR agencies. This makes it very interesting for Start-Ups that want to roll out internationally with fast results and high ROI. BondPR Worldwide is structured around a “One Team” approach. One Team means one central point of contact, one senior ‘go to’ consultant dedicated to ensuring your campaign is orchestrated and conducted to the same high standards everywhere in the world. The business model is based on developing and delivering PR programmes that achieve the maximum results with the minimum administration.
 

Founded in 1988 by Aletta and Peter Stas and driven by passion, Frederique Constant has grown into one of the larger Swiss watch manufacturers. In 2011, production reaches over 120'000 watches, sold in over 2'700 points of sale in 100+ countries around the globe. Frederique Constant positions itself in the Accessible Luxury segment, with most of its watches selling at CHF 1'000-5'000 retail. The company is expected to continue its annual 25% growth, doubling in size every three years. Over the years, we have earned a reputation as a leading maker of Swiss luxury watches despite the relative youth of our brand. The quality of our watches and the detail involved in crafting each watch is only part of our success story; the rest was driven by watch aficionados and lovers of our brand who saw that we had something different and unique to offer. It is by appealing to this same group of people that we hope to make a difference in the lives of many by soliciting for their support to extend the same affection they have for the brand, towards charities and causes we are associated with.
 
 

Hosting Partner

  

The mission of the Department for Economic Affairs of the State of Vaud is to put in place the framework conditions required to promote economic growth. Its objectives are designed to highlight the know-how of companies and to make the canton an attractive and competitive environment.

The vitality of economy in the Canton of Vaud is particularly remarkable in state-of-the-art industries with high added value such as life sciences, information technology, micro- and nanotechnology, environmental and agri-food technologies. Strong political support and many concrete state support and incentives serve to reinforce growth in these sectors.
 
 

Gold Partner
Medtronic is the world’s largest medical technology company, offering an unprecedented breadth and depth of innovative therapies to fulfill our Mission of alleviating pain, restoring health, and extending life. Last year, more than 9 million people benefited from our medical therapies, which treat cardiac and vascular diseases, diabetes, and neurological and musculoskeletal conditions.
 


 

Silver Partner

Euronext is the primary exchange in the Euro zone with over 1 300 issuers worth €2.2 trillion in market capitalization, an unmatched blue chip franchise consisting of 20+ issuers in the EURO STOXX 50® benchmark and a strong diverse domestic and international client base.  
Euronext operates regulated and transparent equity and derivatives markets. Its total product offering includes Equities, Exchange Traded Funds, Warrants & Certificates, Bonds, Derivatives, Commodities and Indices. 
Euronext also leverages its expertise of running markets by providing technology and managed services to third parties.  Its regulated markets are Euronext, Alternext and the Free Market; in addition it offers EnterNext, which facilitates SMEs’ access to capital markets.  Euronext is a wholly owned subsidiary of IntercontinentalExchange Group (ICE).
 

Bronze Partner
 

Merck Global Health Innovation Fund (Merck GHI) is evolving corporate healthcare venture capital globally by utilizing their healthcare ecosystem strategy.  This investment strategy connects innovative companies with complementary technologies to develop integrated healthcare solutions. Merck GHI has $500M under management and provides growth capital to emerging healthcare technology companies worldwide while leveraging the vast R&D-based, global resources of Merck. With a vision that data will be the currency in healthcare, GHI invests broadly in digital health.  GHI invests in platform companies with proven technologies or business models where Merck's expertise and perspectives can accelerate revenue growth and enhance value creation.   Since late 2010, Merck GHI has made over 20 investments in Digital Health companies.


 

Local Support Partners
 
The Ambient Assisted Living Joint Programme (AAL JP) is a European programme with the aim of enhancing the quality of life of older people and strengthening the industrial base in Europe through the use of Information and Communication Technologies (ICT). 
The programme is financed by the European Commission and the 22 countries that constitute the Partner States of this Joint Programme. The overall budget is of € 600 Mil to co-finance Research & Development & Innovation projects aiming to deliver concrete solutions for independent living or ‘ageing well’ of elderly people using ICT. Through the funding of new projects, the AAL JP aims to reinforce the European market for Ambient Assisted Living products and services.
The programme co-funds projects within user-driven-innovation paradigm between a minimum three partners from AAL JP Partner States. The time-frame for market introduction is two to three years after the end of the project. All projects have a human centric approach as the end users are involved from the very beginning of the project life-cycle.
Six calls for proposal were launched so far and a new one is in the publication phase.The second phase of the programme is under discussion but and it is likely to continue until 2020.
 
 
The Boston Consulting Group (BCG) is a global management consulting firm and the world's leading advisor on business strategy. We partner with clients from the private, public, and not-for-profit sectors in all regions to identify their highest-value opportunities, address their most critical challenges, and transform their enterprises. Our customized approach combines deep insight into the dynamics of companies and markets with close collaboration at all levels of the client organization. This ensures that our clients achieve sustainable competitive advantage, build more capable organizations, and secure lasting results. Founded in 1963, BCG is a private company with 81 offices in 45 countries. 
BCG is at the forefront of strategic issues in health care and a leader in value creation and business model innovation. With a global network of health care experts, our health care clients span the industry, including the world’s major producers of medical devices and technology, pharmaceutical and biotech companies, national health care systems, payers, and providers.  
 
 
 

Oracle Health Sciences is a leading strategic software solutions provider to pharmaceutical, biotechnology, medical device and healthcare organizations. We are transforming clinical R&D from pipeline to patient; helping organizations improve patient outcomes by providing actionable insights from aggregated clinical and healthcare data while optimizing clinical trial efficiency and productivity.

 

Salus Partners is a Swiss based investment and advisory firm active in the financial and healthcare industries. We have a special expertise in proven health technologies and seek to generate exceptional returns while bringing good outcomes to society. Salus Partners delivers independent wealth optimization advise and applies its expertise on potential Direct and Co-investment opportunities.

Industry Partner
Eucomed represents the medical technology industry in Europe. Our mission is to make modern, innovative and reliable medical technology available to more people. Eucomed members include both national and pan-European trade and product associations as well as medical technology manufacturers. In total we represent around 25,000 designers, manufacturers and suppliers of medical technology used in the diagnosis, prevention, treatment and amelioration of disease and disability.
The industry we represent employs more than 575,000 people, with a market size that is estimated at roughly € 100 billion in Europe and encompasses more than 500,000 different medical technologies from sticking plasters and wheel chairs through to pacemakers and replacement joints.
Eucomed promotes a balanced policy environment that enables our industry to meet the growing healthcare needs and expectations of our stakeholders. We maintain a close dialogue with them and demonstrate the value of medical technology through health-economic research, data collection, membership services and clear communications.
 

 

Media & Communication Partners
 
Founded in 1993, Cukierman & Co. Investment House Ltd. is the leading Israeli investment house, providing a full array of services including M&A, Public Offerings, Consulting and Family Office Services to Israeli and European companies. With over €4B in transactions, we have the largest Corporate Finance team in Israel with dedicated experts in the Life Sciences, TMT, Green Technology and Real Estate industries. Our Private Equity activities include Catalyst Funds, which rank among the best performing Israeli private equity funds. In light of the growth of the BRIC countries, Catalyst has decided to finance the international expansion of Israeli companies in the emerging markets. 
Established in 2006 as the Life Sciences Corporate Finance arm of Cukierman & Co. Investment House, Cukierman & Co. Life Sciences provides investment banking services to public & private companies from global Life Sciences sectors, including biotechnology and pharmaceuticals, medical devices and healthcare information technology. We are engaged in debt and equity transactions, M&A, IPO advisory services, Corporate Partnering and Licensing Agreements. Our mission is to assist healthcare companies in identifying, negotiating and closing in & out licensing, strategic partnerships, M&A transactions and equity financings; and investors in selecting, evaluating, acquiring/divesting products, businesses and companies in the life sciences industry.

 

Founded in1998 GoingPublic Media AG is today one of the leading publishers of magazines on corporate finance, technology, and capital markets. In addition to the monthly issued GoingPublic Magazin and its well known special editions like “Biotechnology” or “Corporate Finance & Private Equity Guide”, the company publishes monthly the VentureCapital Magazin. It stands as a hub for the private equity and venture capital industry in German speaking Europe and addresses investors and entrepreneurs. The monthly issued magazine Smart Investor addresses retail investors. The six times a year published HV Magazin is directed to the GM-responsibles (board members, investor relations managers etc.) of listed companies. The likewise young publication Unternehmeredition, focuses six times a year mediumsized business entrepreneurs. In 2008 DIE STIFTUNG became part of publication programme of GoingPublic Media. The magazine appears with the highest coverage (15.000 recipients) within the foundation and private wealth market in German speaking Europe. In its corporate publishing division “GoingPublic Services” about ten magazines and newsletters are annually produced on behalf of corporate customers as Deutsches Aktieninstitut, the association of German listed companies (“Finanzplatz”). GoingPublic Media is listed in the Open Market of Frankfurt Stock Exchange (WKN 761 210) and in M:access of Munich Stock Exchange. All publications are published in German.